Merck 2014 Annual Report Download - page 175

170 CONSOLIDATED FINANCIAL STATEMENTS → Consolidated Balance Sheet
CONSOLIDATED BALANCE SHEET
€million Note Dec. 31, 2014 Dec. 31, 2013
Current assets
Cash and cash equivalents → 35 2,878.5 980.8
Current financial assets → 36 2,199.4 2,410.5
Trade accounts receivable → 37 2,235.6 2,021.4
Inventories → 38 1,659.7 1,474.2
Other current assets → 39 1,210.2 360.7
Income tax receivables → 40 297.0 109.8
Assets held for sale → 4 – 27.1
10,480.4 7,384.5
Non-current assets
Intangible assets → 41 11,395.5 9,867.2
Property, plant and equipment → 42 2,990.4 2,647.2
Non-current financial assets → 43 94.4 77.8
Other non-current assets → 39 56.5 105.5
Deferred tax assets → 32 992.9 736.4
15,529.7 13,434.1
Total assets 26,010.1 20,818.6
Current liabilities
Current financial liabilities → 44 2,075.9 440.4
Trade accounts payable → 45 1,539.4 1,364.1
Other current liabilities → 46 1,574.6 1,134.5
Income tax liabilities → 47 849.8 465.1
Current provisions → 48 561.7 494.7
Liabilities directly related to assets held for sale – –
6,601.4 3,898.8
Non-current liabilities
Non-current financial liabilities → 44 3,561.1 3,257.5
Other non-current liabilities → 46 782.0 5.6
Non-current provisions → 48 626.1 1,011.1
Provisions for pensions and other post-employment benefits → 49 1,820.1 910.9
Deferred tax liabilities → 32 818.4 665.5
7,607.7 5,850.6
Equity → 50
Equity capital 565.2 565.2
Reserves 9,038.9 9,341.1
Gains / losses recognized immediately in equity 2,137.5 1,113.7
Equity attributable to MerckKGaA, Darmstadt, Germany, shareholders 11,741.6 11,020.0
Non-controlling interests 59.4 49.2
11,801.0 11,069.2
Total liabilities and equity 26,010.1 20,818.6